NDC 63323-258-01 - Methylprednisolone Sodium Succinate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-258
- Requested NDC
- 63323-258-01
- Package NDCs from labels
- 63323-258-01, 63323-258-03
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methylprednisolone Sodium Succinate - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Methylprednisolone Sodium Succinate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-03-02 | HUMAN PRESCRIPTION DRUG LABEL |
| methylPREDNISolone Sodium Succinate for Injection, USP | REMEDYREPACK INC. | 2020-11-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-258-01 | Methylprednisolone Sodium Succinate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 2 | 7 | |
| 63323-258-03 | Methylprednisolone Sodium Succinate | 25 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-258 | METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE SODIUM SUCCINATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20230509_c5d22210-73c6-4697-a267-75e243508642.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-258-01 | EA - Each | 63323-258 | 1ab8bf02-6730-4148-9b7c-4caf12626fca | 1 | 2024-07-12 |
| 63323-258-03 | EA - Each | 63323-258 | 5689026c-6fa7-45f5-ab08-a9eb9d879c9d | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SOLU-MEDROL | SOLU-MEDROL | HF Acquisition Co. LLC, DBA HealthFirst | 74e5060c-8426-1b77-e053-2a91aa0a1f13 | 2024-02-22 | Warnings, Adverse reactions | 311659 LEC9GKY20K |
| Monobasic Sodium Phosphate and Dibasic Sodium Phosphate | MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE | Lupin Pharmaceuticals,Inc. | e2fcc382-6fac-4438-ad02-ebc8528dd59a | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 22ADO53M6F |
| SOLU-MEDROL | SOLU-MEDROL | HF Acquisition Co. LLC, DBA HealthFirst | 74e448ed-f4b4-8d09-e053-2991aa0a7500 | 2024-01-29 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| CVS Maximum Strength LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | CVS Pharmacy Inc. | e6aff579-affb-41bb-8e36-53ea484cb0c5 | 2023-11-26 | Warnings | LKG8494WBH |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | LKG8494WBH |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | LKG8494WBH |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | LKG8494WBH |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Medical Purchasing Solutions, LLC | 6a26a977-95dd-cdae-e053-2a91aa0a8b0a | 2023-05-30 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Medical Purchasing Solutions, LLC | dd2bfa31-9eae-2baa-e053-2a95a90a9db7 | 2023-05-23 | Warnings, Adverse reactions | 311659 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Medical Purchasing Solutions, LLC | b635e21b-d68d-f60b-e053-2995a90a0f46 | 2023-05-08 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Fresenius Kabi USA, LLC | c5d22210-73c6-4697-a267-75e243508642 | 2023-03-02 | Warnings, Adverse reactions | ANDA040612 ANDA040583 63323-258-03 63323-255-01 63323-258-01 63323-265-30 63323-255-03 63323-265 63323-255 63323-258 63323025801 1743704 314099 311659 dc369096-3042-4942-9aeb-bbdf98f35bb8 c5d22210-73c6-4697-a267-75e243508642 LEC9GKY20K |
| K-Phos No. 2 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | Beach Products, Inc. | 9f446400-c403-4971-879e-1341f7f7d9da | 2023-02-23 | Adverse reactions | KH7I04HPUU |
| K Phos Neutral | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Beach Products, Inc. | 83376725-ee0f-40ad-bd90-31a61b9445cf | 2023-02-23 | Adverse reactions | 22ADO53M6F |
| NAT. PHOS. | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | Hyland's Inc. | 9ad86f9f-df9e-4e5c-bce4-571e1da44145 | 2022-12-19 | Warnings | 22ADO53M6F |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | Fresenius Kabi USA, LLC | 5bf47be3-f3fe-452b-8113-941796498345 | 2022-03-31 | Warnings, Adverse reactions | 22ADO53M6F |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Fresenius Kabi USA, LLC | e6169d3b-39d2-47f9-8d5b-b53ec069a722 | 2021-07-23 | Warnings, Adverse reactions | 22ADO53M6F |
| c4e5206c-c518-10a3-e053-2995a90acb1d | b4e75a4f-e048-4b1d-b9c6-2d79e8b9a6b1 | 2021-06-16 | Warnings, Adverse reactions | b4e75a4f-e048-4b1d-b9c6-2d79e8b9a6b1 | ||
| Ivy-Dry Super | BENZYL ALCOHOL, CAMPHOR, MENTHOL | Ivy-Dry, Inc. | 4792a667-2378-4b3d-968d-9efb1866792f | 2017-12-27 | Warnings | LKG8494WBH |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.